Novartis Bioventures Ltd is 10% at Marina Biotech, Inc. (MRNA). They have made 27 open-market trades across 11 companies since 2011, most recently 2020-06-19.
5 open-market purchases totalling $9.6M since 2014, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRNA | 2,568,565 | $558.8M |
| ARPO | 4,862,363 | $160.5M |
| RARX | 2,320,691 | $111.4M |
| AGLE | 2,175,314 | $26.1M |
| ALT | 8,345,145 | $18.3M |
| ALRN | 2,250,344 | $4.7M |
| BCYC | 964,645 | $3.3M |
| AKBA | 3,405,764 | $2.3M |
| GRTX | 3,469,273 | $503K |
| TKAI | 4,545,496 | — |
| CLDN | 1,372,798 | — |
| PrivateUnlisted | 5,805,550 | — |
| Total | $885.9M |
Shares reported on the most recent Form 4, priced at the 2020-06-22 close. 3 holdings could not be priced and are excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 85% | 70% | 95% |
| Avg Move | -10.6% | -7.3% | -21.4% |
| Scored | 20 | 20 | 20 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTX | SELL | 2020-06-18 | 2020-06-22 | $8.25 | $8.3M | -18.9% | -10.1% | -11.5% |
| GRTX | SELL | 2020-06-05 | 2020-06-09 | $9.60 | $342K | -11.6% | -24.0% | -16.2% |
| GRTX | SELL | 2020-06-02 | 2020-06-04 | $9.70 | $251K | -6.2% | -25.6% | -19.0% |
| BCYC | BUY | 2019-05-28 | 2019-05-30 | $14.00 | $2.4M | +0.0% | -16.8% | -43.4% |
| ARPO | SELL | 2019-04-11 | 2019-04-15 | $1.06 | $185K | +6.7% | +6.5% | -14.1% |
| ARPO | SELL | 2019-04-08 | 2019-04-10 | $1.08 | $367K | -8.7% | -8.7% | -28.7% |
| ARPO | SELL | 2019-04-03 | 2019-04-05 | $0.98 | $185K | -10.2% | -1.9% | -16.7% |
| ARPO | SELL | 2019-03-29 | 2019-04-02 | $0.95 | $380K | +5.1% | +4.0% | -12.0% |
| ALRN | SELL | 2019-03-13 | 2019-03-15 | $2.08 | $673K | -8.2% | -10.3% | -54.9% |
| ALRN | SELL | 2018-08-14 | 2018-08-16 | $2.21 | $13K | +14.8% | +37.4% | +8.9% |
| ALRN | SELL | 2018-08-10 | 2018-08-14 | $2.42 | $17K | -6.9% | +29.9% | -21.2% |
| ALRN | SELL | 2018-07-31 | 2018-08-02 | $3.17 | $40K | -32.3% | +4.5% | -29.0% |
| ALRN | SELL | 2018-07-27 | 2018-07-31 | $3.35 | $28K | -21.0% | -1.0% | -23.6% |
| ALRN | SELL | 2018-07-25 | 2018-07-27 | $3.76 | $77K | -21.7% | -32.2% | -31.6% |
| ALRN | SELL | 2018-07-16 | 2018-07-18 | $4.72 | $60K | -31.0% | -56.7% | -39.4% |
| AGLE | SELL | 2018-05-11 | 2018-05-14 | $10.06 | $197K | -5.2% | -1.6% | -6.3% |
| AGLE | SELL | 2018-05-09 | 2018-05-11 | $10.12 | $1.5M | -0.3% | +0.7% | -3.4% |
| RARX | SELL | 2017-06-02 | 2017-06-06 | $23.38 | $919K | -6.7% | -18.7% | -37.6% |
| RARX | SELL | 2017-05-18 | 2017-05-22 | $25.50 | $460K | -4.7% | -7.8% | -40.2% |
| PrivateAerpio Pharmaceuticals, Inc. | BUY | 2017-03-15 | 2017-03-17 | $5.00 | $2.8M | N/A | N/A | N/A |
| RARX | BUY | 2016-10-31 | 2016-10-31 | $13.00 | $4K | -1.4% | -3.2% | +16.6% |
| TKAI | SELL | 2015-06-16 | 2015-06-18 | $14.27 | $16K | N/A | N/A | N/A |
| TKAI | SELL | 2015-06-11 | 2015-06-12 | $14.20 | $396K | N/A | N/A | N/A |
| AKBA | BUY | 2014-03-25 | 2014-03-27 | $17.00 | $3.1M | -38.5% | -0.9% | -0.9% |
| CLDN | BUY | 2014-02-04 | 2014-02-06 | $8.00 | $1.3M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.